AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

OSTEOMICS: Identifying Regulators of Bone Homeostasis

Recruitingn/aAges 18 Years - 110 YearsAllRelation Therapeutics
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Diseases of bone associated with ageing, including osteoporosis (OP) and osteoarthritis (OA), reduce bone mass, bone strength and joint integrity. Current non-surgical approaches are limited to pharmaceutical agents that are not disease modifying and have poor patient tolerability due to side effect profiles. Developing a fundamental understanding of cellular bone homeostasis, including how key cell types affect tissue health, and offering novel therapeutic targets for prevention of bone disease is therefore essential. This is the focus of OSTEOMICS. A number of factors have been linked to increased risk of bone disease, including genetic predisposition, diet, smoking, ageing, autoimmune disorders and endocrine disorders. In our study, we will recruit patients undergoing elective and non-elective orthopaedic surgery and obtain surgical bone waste for analysis. This will capture a cohort

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Patients with osteoarthritis undergoing total joint arthroplasty, osteotomy or arthrodesis of any joint (including hip, knee, shoulder, wrist, elbow, ankle). 2. Patient with fractured neck of femurs undergoing hemiarthroplasty or total hip arthroplasty, or other internal fixation procedure. 3. Patients undergoing acute low-velocity or fragility fracture fixation surgery. 4. Patients aged between 18-110 years old with capacity to consent. Since deteriorating bone health including diseases like osteoporosis are primarily conditions of older age there is no practical upper age-limit. However, study involvement is limited by suitability for surgery which encompasses multiple factors considered on an individual case basis including age, frailty, comorbidities, baseline mobility, renal function and ability to consent (for instance due to dementia or delirium). We note that our inclusion criteria is purposefully broad as we aim to deduce trends across a wide range of conditions and backgrounds. Exclusion Criteria: 1. Patients unable to provide informed consent. 2. Patients with suspected/established underlying malignancy. 3. Patients with suspected/established osteomyelitis. 4. Patients with suspected/established bloodborne disease 5. Patients who are currently a subject of a clinical trial involving an investigational medicinal product.
๐Ÿ’Š

What it tests

  • Relevant orthopaedic surgery
๐Ÿ“

Where

8 sites
Harley Street Specialist Hospital
London, United Kingdom
Barts Health NHS Trust
London, United Kingdom
Chase Farm Hospital
London, United Kingdom
Fitzrovia Hospital/QASMC
London, United Kingdom
King's College Hospital
London, United Kingdom
Luton & Dunstable University Hospital
London, United Kingdom
Royal National Orthopaedic Hospital NHS Trust
London, United Kingdom
West Middlesex University Hospital
London, United Kingdom
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy